For instance, a study published by Rodriguez and colleagues in 2020 evaluated visual acuity in children aged over 4 years treated with anti-VEGF, comparing their visual acuity with that measured in the ET-ROP study published in 2010 [70]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.